Quest Diagnostics
DGX
Quest Diagnostics (DGX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $260.00 from $250.00 | Oct 7, 2026 |
| Truist Securities | Maintained | Hold | $260.00 from $250.00 | Sep 21, 2026 |
| UBS | Maintained | Neutral | $245.00 from $232.00 | Sep 8, 2026 |
| JP Morgan | Maintained | Neutral | $250.00 from $220.00 | Jul 28, 2026 |
| Baird | Maintained | Neutral | $255.00 from $236.00 | Jul 24, 2026 |
| Barclays | Maintained | Overweight | $250.00 from $230.00 | Jul 24, 2026 |
| Truist Securities | Maintained | Hold | $250.00 from $225.00 | Jul 24, 2026 |
| Mizuho | Maintained | Outperform | $260.00 from $235.00 | Jul 24, 2026 |
| UBS | Maintained | Neutral | $232.00 from $220.00 | Jul 24, 2026 |
| Baird | Maintained | Neutral | $236.00 from $232.00 | Jul 13, 2026 |
| Truist Securities | Maintained | Hold | $225.00 from $220.00 | Apr 22, 2026 |
| Barclays | Maintained | Overweight | $230.00 from $225.00 | Apr 22, 2026 |
| Baird | Maintained | Neutral | $229.00 from $224.00 | Apr 22, 2026 |
| UBS | Maintained | Neutral | $220.00 from $210.00 | Apr 22, 2026 |
| Evercore ISI Group | Maintained | In-Line | $210.00 from $220.00 | Apr 8, 2026 |
| Mizuho | Maintained | Outperform | $235.00 from $210.00 | Feb 12, 2026 |
| Jefferies | Maintained | Buy | $220.00 from $215.00 | Feb 11, 2026 |
| Evercore ISI Group | Maintained | In-Line | $220.00 from $190.00 | Feb 11, 2026 |
| Barclays | Maintained | Overweight | $225.00 from $210.00 | Feb 11, 2026 |
| UBS | Maintained | Neutral | $210.00 from $190.00 | Feb 11, 2026 |
Frequently asked questions
What is the latest analyst rating on DGX?
On Oct 7, 2026, Barclays maintained Quest Diagnostics at Overweight with a price target of $260.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
